Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Poster P098

Anti-TNF Biologic Therapy Does Not Increase Postoperative Morbidity in Pediatric Crohn`s Patients

AIBD

BACKGROUND: Limited knowledge exists as to what impact preoperative biologic therapy has on post-operative complications in pediatric patients undergoing abdominal surgery for Crohn’s disease (CD). Therefore, we sought to determine the 30-day postoperative infectious complication rate among pediatric CD patients who received biologic therapy within 12 weeks of an abdominal operation.   METHODS: A retrospective chart review was performed on pediatric (

Advertisement

Advertisement

Advertisement